BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma
Juliet Richman, Juan Martin-Liberal, Stefan Diem & James Larkin
Dual BRAF and MEK inhibition in advanced BRAF-mutated melanoma is superior to single inhibition in terms of efficacy without significant increase in toxicity. Therefore, BRAF plus MEK inhibition is expected to supersede single-agent BRAF inhibition in these patients in the near future.
|citation||Richman J, Martin-Liberal J, Diem S, Larkin J. BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma. Expert Opin Pharmacother 2015; 16:1285-97.|
|type||journal paper/review (English)|
|date of publishing||6-2015|
|journal title||Expert Opin Pharmacother (16/9)|